ArticleInternational journal of molecular sciences2023

The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice.

Johannes Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.